KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Contacts KalVista Pharmaceuticals, Inc. Ryan Baker Head, Investor Relations (617) 771-5001 ryan.baker@kalvista.com KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced that...